...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Combination of Ligusticum Chuanxiong and Radix Paeonia Promotes Angiogenesis in Ischemic Myocardium through Notch Signalling and Mobilization of Stem Cells
【24h】

Combination of Ligusticum Chuanxiong and Radix Paeonia Promotes Angiogenesis in Ischemic Myocardium through Notch Signalling and Mobilization of Stem Cells

机译:通过Notch信号传导和干细胞的动员促使肺炎和芍药的组合促进缺血性心肌中的血管生成

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective. To study the cardioprotective mechanism by which the combination of Chuanxiong (CX) and Chishao (CS) promotes angiogenesis. Methods. Myocardial infarction (MI) mouse models were induced by ligation of the left anterior descending coronary artery. The effects on cardiac function were evaluated in the perindopril tert-butylamine group (PB group) (3mg/kg/d), CX group (55mg/kg/d), CS group (55mg/kg/d), and CX and CS combination (CX-CS) group (27.5mg/kg/d CX plus 27.5mg/kg/d CS). RO4929097, an inhibitor of Notch secretase, was used (10mg/kg/d) to explore the role of Notch signalling in the CX-CS-induced promotion of angiogenesis in the myocardial infarcted border zone (IBZ). The left ventricular ejection fraction (LVEF) and percentage of MI area were evaluated with animal ultrasound and Masson staining. The average optical densities (AODs) of CD31 and vWF in the myocardial IBZ were detected by immunofluorescence. Angiogenesis-related proteins including hypoxia-inducible factor 1-alpha (HIF-1), fibroblast growth factor receptor 1 (FGFR-1), Notch1 and Notch intracellular domain (NICD), and stem cell mobilization-related proteins including stromal cell-derived factor 1 (SDF-1), C-X-C chemokine receptor type 4 (CXCR-4), and cardiotrophin1 were detected by western blot analysis. Results. Compared with the model group, the CX-CS and PB groups both showed markedly improved LVEF and decreased percentage of MI area after 21 days of treatment. Although the CX group and CS group showed increased LVEF and decreased MI areas compared with the model group, the difference was not significant. The AOD of CD31 in the IBZ in both the model and the CX-CS-I group was markedly reduced compared with that in the sham group. CX-CS significantly increased the CD31 AOD in the IBZ and decreased the AODs of CD31 and vWF in the infarct zone compared with those in the model group. The expression of HIF-1 in both the model group and the CX-CS group was higher than that in the sham group. Compared with the model group, the expression of FGFR-1, SDF-1, cardiotrophin1, Notch1, and NICD was increased in the CX-CS group. Notch1 and NICD expression in the CX-CS-I group was reduced compared with that in the CX-CS group. Conclusions. The combination of CX and CS protected cardiomyocytes in the IBZ better than CX or CS alone. The mechanism by which CX-CS protects ischemic myocardium may be related to the proangiogenesis effect of CX-CS exerted through Notch signalling and the mobilization of stem cells to the IBZ.
机译:客观的。研究川芎(CX)和Chishao(CS)促进血管生成的心脏保护机制。方法。通过结扎左前期下降冠状动脉诱导心肌梗死(MI)小鼠模型。在PerindoProil叔丁胺基团(Pb基团)(3mg / kg / d),Cx基(55mg / kg / d),Cs组(55mg / kg / d)和Cx和Cs中评估了对心脏功能的影响组合(CX-CS)组(27.5mg / kg / d Cx加27.5mg / kg / d Cs)。使用(10mg / kg / d),探测缺口分泌酶的抑制剂(10mg / kg / d)探讨Notch信号传导在心肌梗死边界区(IBZ)中的CX-CS诱导的血管生成促进中的作用。用动物超声和Masson染色评估左心室喷射分数(LVEF)和MI区的百分比。通过免疫荧光检测心肌IBZ中CD31和VWF的平均光密度(AOD)。血管生成相关蛋白质,包括缺氧诱导因子1-α(HIF-1),成纤维细胞生长因子受体1(FGFR-1),Notch1和Notch细胞内结构域(NICD),以及包括基质细胞衍生的干细胞动员相关蛋白质因子1(SDF-1),CXC趋化因子受体型4(CXCR-4)和Cardiotrophin1通过Western印迹分析检测。结果。与模型组相比,CX-Cs和Pb组均显示出明显改善的LVEF和21天治疗后MI面积的百分比减少。虽然CX组和CS组与模型组相比,CX组和CS组显示较高的LVEF和MI区域,但差异并不重要。与假组合相比,模型和CX-CS-I组中IBZ中的CD31的AOD在IBZ中显着降低。与模型组中的相比,CX-CS显着增加了IBZ中的CD31 AOD,并减少了梗塞区中CD31和VWF的AODS。在模型组和CX-CS组中HIF-1的表达高于假组中的表达。与模型组相比,CX-CS组在CX-CS组中增加了FGFR-1,SDF-1,Cardiotrophin1,Notch1和NicD的表达。在CX-CS组中,CX-CS-I组中的Notch1和NICD表达减少。结论。 Cx和Cs的组合优于IBZ的心肌细胞优于Cx或Cs。 CX-CS保护缺血性心肌的机制可能与通过NOTCH信号传导施加的CX-Cs的常规发生效应以及将干细胞的动员到IBZ。

著录项

  • 来源
  • 作者单位

    China Acad Chinese Med Sci Lab Cardiovasc Dis Xiyuan Hosp Beijing 100091 Peoples R China;

    Qingdao Univ Affiliated Hosp TCM Dept Qingdao 266003 Shandong Peoples R China;

    China Acad Chinese Med Sci Lab Cardiovasc Dis Xiyuan Hosp Beijing 100091 Peoples R China;

    China Acad Chinese Med Sci Xiyuan Hosp Dept Neurol Beijing 100091 Peoples R China;

    China Acad Chinese Med Sci Lab Cardiovasc Dis Xiyuan Hosp Beijing 100091 Peoples R China;

    China Acad Chinese Med Sci Xiyuan Hosp Dept Pharm Beijing 100091 Peoples R China;

    China Acad Chinese Med Sci Lab Cardiovasc Dis Xiyuan Hosp Beijing 100091 Peoples R China;

    China Acad Chinese Med Sci Lab Cardiovasc Dis Xiyuan Hosp Beijing 100091 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 临床医学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号